Drugs / Fermagate
Fermagate
also known as
Alpharen · Alpharen, magnesium iron hydroxycarbonate · Fermagato · Magnesium iron hydroxycarbonate
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT00436683 | Feb 2007 → Jan 2008 | chronic renal failure syndrome | Ineos Healthcare Limited | Completed | No outcome recorded |
| Phase 2 | NCT00358722 | Jul 2006 → May 2008 | chronic renal failure syndrome | Ineos Healthcare Limited | Terminated | No outcome recorded |
| Phase 2 | NCT00317694 | Mar 2006 → Jun 2007 | chronic renal failure syndrome | Ineos Healthcare Limited | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00841126 | Jul 2009 → Jul 2011 | chronic renal failure syndrome | Ineos Healthcare Limited | Terminated | No outcome recorded |
| Phase 3 | NCT00844662 | Jul 2009 → Sep 2011 | chronic renal failure syndrome | Ineos Healthcare Limited | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fermagate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00317694 ↗ |
| Known as | Alpharen | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297751 ↗ |
| Known as | Alpharen, magnesium iron hydroxycarbonate | “Alpharen, magnesium iron hydroxycarbonate” NCT00841126 ↗ |
| Known as | Fermagato | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297751 ↗ |
| Known as | Magnesium iron hydroxycarbonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00841126 ↗ |
| Route | Oral | “500 mg tablets, administered orally” NCT00841126 ↗ |